Remission of Glucocorticoid-Resistant Polymyalgia Rheumatica achieved with Tocilizumab: 2 Case Reports
<p>Polymyalgia rheumatica (PMR) is an idiopathic inflammatory disease characterized by pain and stiffness around the shoulders, neck and hips. IL-6 is an important cytokine in the pathogenesis of the disease. Although glucocorticoids (GC) are the current basic treatment, approximately 50% of p...
Saved in:
Main Author: | Ayse Unal Enginar (Author) |
---|---|
Format: | Book |
Published: |
Rheumatica Acta: Open Access - Peertechz Publications,
2017-11-20.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica
by: Federica Filippi, et al.
Published: (2019) -
Polymyalgia rheumatica (PMR)
by: Jan Tore Gran, et al.
Published: (2008) -
Imaging in polymyalgia rheumatica
by: N. Possemato, et al.
Published: (2018) -
Comorbidity in polymyalgia rheumatica
by: C. Chatzigeorgiou, et al.
Published: (2018) -
Pathogenesis of polymyalgia rheumatica
by: G. Guggino, et al.
Published: (2018)